ArticleCancer discovery2013

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.

Nadine S Jahchan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.